Franklin Resources’s Autolus Therapeutics AUTL Stock Holding History

Franklin Resources’s Portfolio AUTL Stock Details AUTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-10,000	Closed	-$41.8K	–	2928
2024 Q3	$41.8K	Hold	10,000	–	–	﹤0.01%	2810
2024 Q2	$34.8K	Hold	10,000	–	–	﹤0.01%	2753
2024 Q1	$63.8K	Buy	+10,000	New	+$62.4K	﹤0.01%	2753
2021 Q1	–	Sell	-570,455	Closed	-$5.1M	–	1981
2020 Q4	$5.1M	Hold	570,455	–	–	﹤0.01%	1095
2020 Q3	$6.64M	Buy	570,455 +25,000	+5%	+$363K	﹤0.01%	989
2020 Q2	$8.75M	Hold	545,455	–	–	﹤0.01%	897
2020 Q1	$3.27M	Buy	+545,455	New	+$5.04M	﹤0.01%	1003

Other funds holding AUTL

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

TAM

TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Franklin Resources's AUTL Position: Q4 2024 in Review

Franklin Resources sold out of Autolus Therapeutics (AUTL) in Q4 2024, closing a stake of 10,000 shares — an estimated $41.8K sold.

Franklin Resources first reported a position in AUTL in Q1 2020 and held it in 7 quarters. The position peaked at $8.75M in Q2 2020. 110 funds tracked by Wall St. Rank hold AUTL as of Q4 2024.

Franklin Resources reported no remaining Autolus Therapeutics position as of Q4 2024 after selling out during the quarter.
Franklin Resources sold 10,000 Autolus Therapeutics shares in Q4 2024, an estimated $41.8K.
Franklin Resources first reported a position in Autolus Therapeutics in Q1 2020 and held it in 7 quarters.
Franklin Resources's Autolus Therapeutics position peaked at $8.75M in Q2 2020.
110 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q4 2024.

Based on Franklin Resources's 13F filing for Q4 2024, filed 12 Feb 2025.